0      0

AONN+ Annual 2021 Virtual Conference

FRI06 - Industry Sponsored Session | Advances in targeted therapy for CLL and AML: Efficacy and practical management of BCL-2 inhibitors Presented by AbbVie

Nov 19, 2021 12:30pm ‐ Nov 19, 2021 1:30pm


This session will provide advanced practitioners an understanding of venetoclax safety and efficacy data. In addition, the practical management of venetoclax therapy in patients with CLL and AML will be discussed.


You must be logged in and own this session in order to post comments.